A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found those insured through Medicare Advantage received less expensive cancer drugs compared to others on Traditional Medicare.
Medicare Advantage leads to lower cancer drug costs in colorectal cancer
- Post author:admin
- Post published:January 10, 2025
- Post category:uncategorized